Table 4:
Cost-utility analysis results under base-case assumptions
| Strategy | Cost, $ | Effect, QALYs | Incremental cost | Incremental effect, QALYs | ICER |
|---|---|---|---|---|---|
| 2 screening programs v. no screening | |||||
| No screening | 0.00 | 23.82 | – | – | – |
| Targeted screening | 63.06 | 23.86 | 63.06 | 0.04 | 1676.94 |
| Universal screening | 162.98 | 23.89 | 162.98 | 0.07 | 2286.06 |
| Universal screening v. targeted screening | |||||
| Targeted screening | 63.06 | 23.86 | – | – | – |
| Universal screening | 162.98 | 23.89 | 99.92 | 0.03 | 2965.96 |
Note: ICER = incremental cost-effectiveness ratio, QALY = quality-adjusted life year.